Gomberg-Maitland addresses sotatercept’s capacity to improve pulmonary vascular and cardiac endpoints in patients with CpcPH-HFpEF.
Mardi Gomberg-Maitland, MD, MSc
Advertisement
Mardi Gomberg-Maitland, MD, MSc, is the director of the pulmonary hypertension program, chief clinical research officer at the Office of Clinical Research SMHS, and a professor of medicine at George Washington University.
Articles by Mardi Gomberg-Maitland, MD, MSc
Advertisement